UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer

Journal of clinical oncology, 2018-10, Vol.36 (29), p.2943-2949

2018

Volltextzugriff (PDF)

Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial

International journal of radiation oncology, biology, physics, 2014-04, Vol.88 (5), p.1074-1084

2014

Volltextzugriff (PDF)

Long-Term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease?

International journal of radiation oncology, biology, physics, 2011-04, Vol.79 (5), p.1310-1317

2011

Volltextzugriff (PDF)

Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States

The Journal of urology, 2014-12, Vol.192 (6), p.1650-1656

2014

Volltextzugriff (PDF)

Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience

Radiation oncology (London, England), 2017-05, Vol.12 (1), p.79-79, Article 79

2017

Volltextzugriff (PDF)

Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?

International journal of radiation oncology, biology, physics, 2013-03, Vol.85 (3), p.693-699

2013

Volltextzugriff (PDF)

Do Angiotensin-Converting Enzyme Inhibitors Reduce the Risk of Symptomatic Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer After Definitive Radiation Therapy? Analysis of a Single-Institution Database

International journal of radiation oncology, biology, physics, 2013-12, Vol.87 (5), p.1071-1077

2013

Volltextzugriff (PDF)

Functional Promoter Variant rs2868371 of HSPB1 Is Associated With Risk of Radiation Pneumonitis After Chemoradiation for Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2013-04, Vol.85 (5), p.1332-1339

2013

Volltextzugriff (PDF)

Changes in Pulmonary Function After Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, or Proton Beam Therapy for Non-Small-Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2012-07, Vol.83 (4), p.e537-e543

2012

Volltextzugriff (PDF)

Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis

American journal of clinical oncology, 2018-01, Vol.41 (1), p.46-52

2018

Volltextzugriff (PDF)

Association Between White Blood Cell Count Following Radiation Therapy With Radiation Pneumonitis in Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.319-325

2014

Volltextzugriff (PDF)

Urinary Side Effects and Complications After Permanent Prostate Brachytherapy: The MD Anderson Cancer Center Experience

Urology (Ridgewood, N.J.), 2009-09, Vol.74 (3), p.601-605

2009

Volltextzugriff (PDF)

The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy

Translational oncology, 2017-04, Vol.10 (2), p.197-202

2017

Volltextzugriff (PDF)

Change in Diffusing Capacity After Radiation as an Objective Measure for Grading Radiation Pneumonitis in Patients Treated for Non-Small-Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2012-08, Vol.83 (5), p.1573-1579

2012

Volltextzugriff (PDF)

Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins

International journal of radiation oncology, biology, physics, 2003-08, Vol.56 (5), p.1218-1224

2003

Volltextzugriff (PDF)

Sexual Function and the Use of Medical Devices or Drugs to Optimize Potency After Prostate Brachytherapy

International journal of radiation oncology, biology, physics, 2012-04, Vol.82 (5), p.e765-e771

2012

Volltextzugriff (PDF)

PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era

International journal of radiation oncology, biology, physics, 2013-01, Vol.85 (1), p.e39-e46

2013

Volltextzugriff (PDF)

Dosimetric Changes Resulting From Patient Rotational Setup Errors in Proton Therapy Prostate Plans

International journal of radiation oncology, biology, physics, 2009-09, Vol.75 (1), p.40-48

2009

Volltextzugriff (PDF)

HSPB1 Gene Polymorphisms Predict Risk of Mortality for US Patients After Radio(chemo)therapy for Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2012-10, Vol.84 (2), p.e229-e235

2012

Volltextzugriff (PDF)

Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?

European journal of cancer (1990), 2012-07, Vol.48 (11), p.1664-1671

2012

Volltextzugriff (PDF)

Survival and toxicity following sequential multimodality treatment including whole abdominopelvic radiotherapy for patients with desmoplastic small round cell tumor

Radiotherapy and oncology, 2016-04, Vol.119 (1), p.40-44

2016

Volltextzugriff (PDF)

Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II–III inoperable non-small cell lung cancer

Radiotherapy and oncology, 2015-06, Vol.115 (3), p.367-372

2015

Volltextzugriff (PDF)

Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas

Clinical cancer research, 2003-11, Vol.9 (14), p.5228-5237

2003

Volltextzugriff (PDF)

Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model

Breast cancer research : BCR, 2015-03, Vol.17 (1), p.42-42, Article 42

2015

Volltextzugriff (PDF)

Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma

Clinical cancer research, 2002-12, Vol.8 (12), p.3686-3695

2002

Volltextzugriff (PDF)

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(325)
Mit Volltextzugriff
(293)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(345)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(237)
Life Sciences & Biomedicine
(194)
Humans
(176)
Male
(111)
Female
(92)
Biological And Medical Sciences
(83)
Medical Sciences
(69)
Adult
(67)
Middle Aged
(65)
Aged
(61)
Oncology
(59)
Physical Sciences
(38)
Astronomy And Astrophysics
(32)
Aged, 80 And Over
(30)
Astronomy & Astrophysics
(28)
Adolescent
(27)
Prostatic Neoplasms - Radiotherapy
(27)
Child
(25)
Hematology, Oncology And Palliative Medicine
(25)
Radiology, Nuclear Medicine & Medical Imaging
(25)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(183)
Journals@Ovid Full Text
(156)
Electronic Journals Library
(148)
Ingenta
(135)
Publisher or Other Site
(120)
Elsevier ScienceDirect Journals Complete
(83)
Wiley-Blackwell Journals
(55)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(55)
IngentaConnect Journals
(55)
Wiley Online Library Full Collection 2018
(36)
Oxford journals
(30)
SpringerLink_现刊
(24)
JSTOR
(20)
Oxford Journals 2020 Medicine
(18)
American Physical Society Journals
(12)
SAGE Journals
(12)
Nature
(10)
Taylor & Francis
(10)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(9)
Nexis Uni
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer

Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofractionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial

Long-Term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease?

Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States

Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience

Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?

Do Angiotensin-Converting Enzyme Inhibitors Reduce the Risk of Symptomatic Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer After Definitive Radiation Therapy? Analysis of a Single-Institution Database

Functional Promoter Variant rs2868371 of HSPB1 Is Associated With Risk of Radiation Pneumonitis After Chemoradiation for Non-Small Cell Lung Cancer

Changes in Pulmonary Function After Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, or Proton Beam Therapy for Non-Small-Cell Lung Cancer

Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis

Association Between White Blood Cell Count Following Radiation Therapy With Radiation Pneumonitis in Non-Small Cell Lung Cancer

Urinary Side Effects and Complications After Permanent Prostate Brachytherapy: The MD Anderson Cancer Center Experience

The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy

Change in Diffusing Capacity After Radiation as an Objective Measure for Grading Radiation Pneumonitis in Patients Treated for Non-Small-Cell Lung Cancer

Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins

Sexual Function and the Use of Medical Devices or Drugs to Optimize Potency After Prostate Brachytherapy

PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era

Dosimetric Changes Resulting From Patient Rotational Setup Errors in Proton Therapy Prostate Plans

HSPB1 Gene Polymorphisms Predict Risk of Mortality for US Patients After Radio(chemo)therapy for Non-Small Cell Lung Cancer

Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease?

Survival and toxicity following sequential multimodality treatment including whole abdominopelvic radiotherapy for patients with desmoplastic small round cell tumor

Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II–III inoperable non-small cell lung cancer

Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas

Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model

Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma

Suchergebnisse filtern